BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29053906)

  • 41. Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients.
    Wang J; Zhang B; Zhang M; Chen J; Deng H; Wang Q; Sun X
    Neuropsychobiology; 2017; 75(2):72-80. PubMed ID: 29065417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study.
    Ma J; Han W; Jiang L
    Brain Dev; 2020 Feb; 42(2):179-184. PubMed ID: 31563418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
    Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
    Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
    Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
    Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.
    Wang N; Zeng Z; Wang B; Qin D; Wang T; Wang C; Guo S
    Neurosci Lett; 2021 Feb; 746():135650. PubMed ID: 33485991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of serum anti-NMDAR antibodies in anti-NMDAR encephalitis mother predicts having healthy newborn.
    Ueda A; Nagao R; Maeda T; Kikuchi K; Murate K; Niimi Y; Shima S; Mutoh T
    Clin Neurol Neurosurg; 2017 Oct; 161():14-16. PubMed ID: 28780398
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
    Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
    Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
    Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
    Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain magnetic resonance-imaging findings of anti-N-methyl-D-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients.
    Wang R; Lai XH; Liu X; Li YJ; Chen C; Li C; Chi XS; Zhou D; Hong Z
    J Neurol; 2018 Feb; 265(2):362-369. PubMed ID: 29249055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-proteomic Analysis Revealed Distinct Protein Profiles in Cerebrospinal Fluid of Patients Between Anti-NMDAR Encephalitis NORSE and Cryptogenic NORSE.
    Wang D; Wu Y; Pan Y; Wang S; Liu G; Gao Y; Xu K
    Mol Neurobiol; 2023 Jan; 60(1):98-115. PubMed ID: 36224320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
    Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
    J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal Fluid Osteopontin and Inflammation-Associated Cytokines in Patients With Anti-
    Zou C; Pei S; Yan W; Lu Q; Zhong X; Chen Q; Pan S; Wang Z; Wang H; Zheng D
    Front Neurol; 2020; 11():519692. PubMed ID: 33250837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late-onset anti-N-methyl-d-aspartate receptor encephalitis in China.
    Zhang L; Liu X; Jiang XY; Wang YH; Li JM; Zhou D
    Epilepsy Behav; 2018 Jul; 84():22-28. PubMed ID: 29734104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allergy in patients with anti-N-methyl-d-aspartate receptor encephalitis.
    Jiang XY; Zhang L; Jiang X; Abdulaziz ATA; Wang YH; Li JM; Zhou D
    Epilepsy Behav; 2018 Feb; 79():188-192. PubMed ID: 29306850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.
    Liu CY; Zhu J; Zheng XY; Ma C; Wang X
    Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
    Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
    Front Immunol; 2019; 10():103. PubMed ID: 30792710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.
    Zhang Y; Liu G; Jiang MD; Li LP; Su YY
    Clin Neurophysiol; 2017 Jul; 128(7):1227-1233. PubMed ID: 28527387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Iizuka T; Kaneko J; Tominaga N; Someko H; Nakamura M; Ishima D; Kitamura E; Masuda R; Oguni E; Yanagisawa T; Kanazawa N; Dalmau J; Nishiyama K
    JAMA Neurol; 2016 Jun; 73(6):706-13. PubMed ID: 27111481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis.
    Yang Y; Zhang B; Li M; Li J
    J Clin Apher; 2021 Dec; 36(6):886-892. PubMed ID: 34520046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents.
    Scheer S; John RM
    J Pediatr Health Care; 2016; 30(4):347-58. PubMed ID: 26507948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.